4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-043974
Chief Operating Officer sold 1,714 shares at $41.23 ($70,668)
- Chief Operating Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bruno Julianne Chief Operating Officer | 2025-03-20 | Option exercise | +3,750 | 12,258 | D | ||
| Bruno Julianne Chief Operating Officer | 2025-03-21 | Sale | −1,714 | $41.23 | $70,668 | 10,544 | D |
| Derivatives | |||||||
| Bruno Julianne Chief Operating Officer | 2025-03-20 | Option exercise · Restricted Stock Units | −3,750 | 11,250 | D | ||
| Open-market sales · 1,714 sh · avg $41.23 · $70,668 | |||||||
Loading xslF345X05/ownership.xml…